Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2023 Jan 25;14:1121124. doi: 10.3389/fendo.2023.1121124

Commentary: Gut microbiota and its derived SCFAs regulate the HPGA to reverse obesity-induced precocious puberty in female rats

Danchun Chen 1,*
PMCID: PMC9905803  PMID: 36761186

Introduction

Central precocious puberty occurs when the hypothalamic–pituitary–gonadal axis (HPGA) activates early, with unknown cause in most girls (1). Notably, children with obesity have more chance of precocious puberty (28). Although intestinal microbiota, as a remote regulator, was involved in the onset of precocious puberty in high- fat diet (HFD) conditions (912), and microbiota- derived SCFAs (short-chain fatty acids) have been characterized as multifunctional molecules impacting human physiology (13), detailed mechanisms remain unclear. Here, Wang et al. found that the reduced microbiota- derived SCFA was accounting for the HFD-induced precocious puberty in female rats (14).

Findings

The authors (14) firstly confirmed that treatment of HFD after weaning induced obesity and precocious puberty in female rats and upregulated HPGA gene expressions, including Kiss1 (kisspeptin-1), GPR54 (G protein-coupled receptor 54, Kiss1R), GnRH (gonadotropin-releasing hormone), Erα (estrogen receptor α) in the hypothalamus, GnRHR (gonadotropin-releasing hormone receptor) in the pituitary, and LHR (luteinizing receptor), FSHR (follicle-stimulating hormone receptor), and Erα in the ovary. In view of flora, the authors found that HFD significantly changed the composition of intestinal microbiota, with increased levels of Bacteroidota, Proteobacteria, and Verrucomicrobiota but decreased levels of Firmicutes. More importantly, they found that HFD reduced SCFAs in the feces of rats. Moreover, dairy-added SCFAs reversed the obesity-induced female precocious puberty and HPGA key gene expressions. The authors also found that SCFA regulated GnRH release, associated with the inhibited GPR54-PKC-ERK1/2 pathway in the hypothalamus.

Novelty and contributions

One of the most important innovations of this study is that the authors identified SCFAs as key mediators of HFD-induced precocious puberty in female rats (14). In addition to providing energy, intestinal SCFAs have been previously recognized to regulate metabolism (13, 15, 16), mucosal function (17), immunity (18), and behaviors (19), while the potential regulation of precocious puberty is underappreciated. The authors found that dairy SCFAs can reverse the HFD-induced precocious puberty, through regulating HPGA functions (14). This finding demonstrated the novel function of SCFAs in the regulation of hypothalamus function. In addition, this study added critical knowledge by identifying SCFA as a messenger mediating the gut–endocrine system remote interactions.

Another important finding of this study is that it explained the mechanism of obesity-induced precocious puberty. Although obesity was found as a risk factor for precocious puberty, and fat-conditioned microbiota is found as an important mediator of this axis, the molecular mechanisms remain elusive. By reconstitution of SCFAs in the HFD, this study found that SCFAs reversed the high fat- induced precocious puberty and the key factors of the HPGA. Hence, the study dissected the new molecular mechanism of obesity- mediated precocious puberty, linking obesity and sexual development.

Potential applications

The golden standard treatment of central precocious puberty is the gonadotropin-releasing hormone agonist (GnRHa), with high efficacy and safety (20, 21). The mechanism of the GnRHa was recognized as suppressing the HPGA and stabilizing pubertal progression (21). However, the treatment has side effects including growth deceleration (22, 23). Thus, there need investigations about the strategies for the medications for the precocious puberty.

There are human studies focusing on the effect of microbiota and their production of SCFAs on glucose and insulin sensitivity (24). Specifically, fiber administration, which facilitated the SCFA- producing microbiota, has been found to favor the outcomes for type 2 diabetes patients (25). In addition, prebiotic functional foods are able to supply SCFAs in treating a variety of disorders including obesity (26). These all give clues for SCFA-involved potential prevention or intervention for precocious puberty.

Discussion

In this study, Wang et al. found that microbiota-derived SCFAs reversed the high-fat- induced obesity- mediated precocious puberty, with mechanisms of impact on the HPGA (14). Hence, a novel remote brake (gut microbiota-SCFA) of precocious puberty was characterized. Future investigations of this braking system are needed for both mechanistic and therapeutic views. Mechanistically, the kinetics and spatial activities of SCFAs need further investigation, which include the incorporation, metabolism, transportation, and transformation. Importantly, the activities of SCFA and downstream signaling pathways remained to be further clarified, either in the intestine or in the hypothalamus or other compartments of the HPGA. In a therapeutic view, attention should be paid to the strategies of administration of SCFA, related drugs, or prebiotics, with extensive diagnostics and detailed analysis of the outcome of treatment. Furthermore, combined treatment would be encouraged to maximize the effectiveness but minimize the side effects of the drugs. Collectively, Wang et al. found a novel mechanism of obesity- mediated precocious puberty, which provides significant knowledge and potential intervention for imbalanced sexual maturation.

Author contributions

The author confirms being the sole contributor of this work and has approved it for publication.

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1. Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol (2016) 4(3):265–74. doi:  10.1016/S2213-8587(15)00380-0 [DOI] [PubMed] [Google Scholar]
  • 2. Liu G, Guo J, Zhang X, Lu Y, Miao J, Xue H. Obesity is a risk factor for central precocious puberty: A case-control study. BMC Pediatr (2021) 21(1):509. doi:  10.1186/s12887-021-02936-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Maia Palhano AC, Kim LJ, Moreira GA, Santos Coelho FM, Tufik S, Levy Andersen M. Narcolepsy, precocious puberty and obesity in the pediatric population: A literature review. Pediatr Endocrinol Rev (2018) 16(2):266–74. doi:  10.17458/per.vol16.2018.Narcolepsypubertyobesity [DOI] [PubMed] [Google Scholar]
  • 4. Huang A, Roth CL. The link between obesity and puberty: what is new? Curr Opin Pediatr (2021) 33(4):449–57. doi:  10.1097/mop.0000000000001035 [DOI] [PubMed] [Google Scholar]
  • 5. Reinehr T, Roth CL. Is there a causal relationship between obesity and puberty? Lancet Child Adolesc Health (2019) 3(1):44–54. doi:  10.1016/S2352-4642(18)30306-7 [DOI] [PubMed] [Google Scholar]
  • 6. Bell JA, Carslake D, Wade KH, Richmond RC, Langdon RJ, Vincent EE, et al. Influence of puberty timing on adiposity and cardiometabolic traits: A mendelian randomisation study. PloS Med (2018) 15(8):e1002641. doi:  10.1371/journal.pmed.1002641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Shearrer GE, Sadler JR, Papantoni A, Burger KS. Earlier onset of menstruation is related to increased body mass index in adulthood and altered functional correlations between visual, task control and somatosensory brain networks. J Neuroendocrinol (2020) 32(12):e12891. doi:  10.1111/jne.12891 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Heras V, Castellano JM, Fernandois D, Velasco I, Rodríguez-Vazquez E, Roa J, et al. Central ceramide signaling mediates obesity-induced precocious puberty. Cell Metab (2020) 32(6):951–66.e8. doi:  10.1016/j.cmet.2020.10.001 [DOI] [PubMed] [Google Scholar]
  • 9. Li Y, Shen L, Huang C, Li X, Chen J, Li SC, et al. Altered nitric oxide induced by gut microbiota reveals the connection between central precocious puberty and obesity. Clin Transl Med (2021) 11(2):e299. doi:  10.1002/ctm2.299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Wang M, Zhang Y, Miller D, Rehman NO, Cheng X, Yeo JY, et al. Microbial reconstitution reverses early female puberty induced by maternal high-fat diet during lactation. Endocrinology (2020) 161(2):bqz041. doi:  10.1210/endocr/bqz041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Bo T, Liu M, Tang L, Lv J, Wen J, Wang D. Effects of high-fat diet during childhood on precocious puberty and gut microbiota in mice. Front Microbiol (2022) 13:930747. doi:  10.3389/fmicb.2022.930747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Aghaee S, Deardorff J, Greenspan LC, Quesenberry CP, Jr., Kushi LH, Kubo A. Breastfeeding and timing of pubertal onset in girls: A multiethnic population-based prospective cohort study. BMC Pediatr (2019) 19(1):277. doi:  10.1186/s12887-019-1661-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc (2021) 80(1):37–49. doi:  10.1017/s0029665120006916 [DOI] [PubMed] [Google Scholar]
  • 14. Wang L, Xu H, Tan B, Yi Q, Liu H, Deng H, et al. Gut microbiota and its derived SCFAs regulate the HPGA to reverse obesity-induced precocious puberty in female rats. Front Endocrinol (Lausanne) (2022) 13:1051797. doi:  10.3389/fendo.2022.1051797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci Rep (2016) 6:37589. doi:  10.1038/srep37589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Liu X, Li X, Xia B, Jin X, Zou Q, Zeng Z, et al. High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metab (2021) 33(5):923–38 e6. doi:  10.1016/j.cmet.2021.02.002 [DOI] [PubMed] [Google Scholar]
  • 17. Zhao Y, Chen F, Wu W, Sun M, Bilotta AJ, Yao S, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol (2018) 11(3):752–62. doi:  10.1038/mi.2017.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun (2020) 11(1):4457. doi:  10.1038/s41467-020-18262-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, et al. Short-chain fatty acids: Microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol (2018) 596(20):4923–44. doi:  10.1113/jp276431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Brito VN, Spinola-Castro AM, Kochi C, Kopacek C, Silva PC, Guerra-Júnior G. Central precocious puberty: Revisiting the diagnosis and therapeutic management. Arch Endocrinol Metab (2016) 60(2):163–72. doi:  10.1590/2359-3997000000144 [DOI] [PubMed] [Google Scholar]
  • 21. Eugster EA. Treatment of central precocious puberty. J Endocr Soc (2019) 3(5):965–72. doi:  10.1210/js.2019-00036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Głąb E, Wikiera B, Bieniasz J, Barg E. The influence of GnRH analog therapy on growth in central precocious puberty. Adv Clin Exp Med (2016) 25(1):27–32. doi:  10.17219/acem/31433 [DOI] [PubMed] [Google Scholar]
  • 23. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Tatò L. Bone development during GH and GnRH analog treatment. Eur J Endocrinol (2004) 151(Suppl 1):S47–54. doi:  10.1530/eje.0.151s047 [DOI] [PubMed] [Google Scholar]
  • 24. Blaak EE, Canfora EE, Theis S, Frost G, Groen AK, Mithieux G, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes (2020) 11(5):411–55. doi:  10.3920/bm2020.0057 [DOI] [PubMed] [Google Scholar]
  • 25. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science (2018) 359(6380):1151–6. doi:  10.1126/science.aao5774 [DOI] [PubMed] [Google Scholar]
  • 26. Green M, Arora K, Prakash S. Microbial medicine: Prebiotic and probiotic functional foods to target obesity and metabolic syndrome. Int J Mol Sci (2020) 21(8):2890. doi:  10.3390/ijms21082890 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES